Saturday 17 October 2026
Export ATR’s income statement to Excel — free account
AptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024. In the quarter to June 2026, revenue grew 6.26%, EPS fell 18.3%, free cash flow fell 23.1% and total debt rose 66.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten.
124.51
0.25
+0.20%
Follow ATR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 13.52% | 14.87% | 15.19% | 15.70% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 6 | 5 | 7 | |
| 7.25% | 8.03% | 8.11% | 8.62% | ||
ROIC |
7.82% | 8.18% | 8.33% | 8.64% | |
Return on Tangible Assets |
15.46% | 16.34% | 16.34% | 21.80% | |
Average Days of Receivables |
83.30 | 78.53 | 77.68 | 79.63 | |
Free Cash Flow per Share |
4.94 | 5.13 | 4.53 | 4.70 | |
Free Cash Flow |
314.58 | 328.66 | 298.11 | 308.70 | |
Capital Expenditures |
(268.89) | (277.29) | (271.89) | (255.84) | |
| Other line items | |||||
Cash ROIC |
7.47% | 7.75% | 6.51% | 7.26% | |
Accounts Receivable Turnover |
4.63 | 4.91 | 5.17 | 4.89 | |
Accounts Payable Turnover |
2.95 | 3.06 | 3.06 | 2.80 | |
Inventory Turnover |
4.54 | 4.74 | 4.75 | 4.38 | |
Average Days of Payables |
128.80 | 125.14 | 126.60 | 136.01 | |
Days of Inventory on Hand |
84.21 | 82.08 | 82.75 | 88.13 | |
Tax Rate |
(0.20) | (0.19) | (0.20) | (0.19) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.90% | 15.98% | 16.06% | 16.21% | |
Share Based Compensation of Revenue |
1.04% | 1.07% | 1.16% | 1.27% | |
Interest Coverage |
7.52 | 8.49 | 9.50 | 10.93 | |
Operating CF/Net income |
1.61 | 1.57 | 1.45 | 1.35 | |
Depreciation/Fixed assets |
0.19 | 0.18 | 0.17 | 0.17 | |
Capex/Depreciation |
(0.88) | (0.93) | (0.95) | (0.92) | |
Revenue per Share |
61.81 | 60.46 | 57.46 | 55.74 | |
Operating CF per Share |
9.17 | 9.46 | 8.67 | 8.59 | |
Capex per Share |
(4.23) | (4.33) | (4.14) | (3.89) | |
Capex to Sales |
0.07 | 0.07 | 0.07 | 0.07 |
Columns are period end dates